Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Ozempic 3.0? Retatrutide — an experimental drug nicknamed “triple G” — could be your best shot at a slimmer waistline when it ...

The U.S. FDA has released ... demonstrate sustained weight loss, which the agency defines as reduction in body fat for at least a year while on a maintenance dose of a medication.

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

Eli Lilly & Co. ( LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026.

Also in today’s edition: ‘no-show’ international student data and significant progress in Israel-Hamas ceasefire talks ...

In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...

"Botox and fillers are not even FDA-approved for most of the places we use them," she noted. "Some individuals might start ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...